Imaging Endpoints is contributing to a new Nature publication showing that Quantitative MRI of vascular disrupting agents may aid cancer drug development.

Archival tumor samples represent a rich resource of annotated specimens for translational genomics research. However,…   Read More

The U.S. Patent and Trademark Office has issued a patent to Imaging Endpoints and Chief…   Read More